Mumbai, Aug. 6 -- On 30 July 2025, the company had announced the signing of an agreement with the Insolvency Administrator of Allecra Therapeutics GmbH (Germany) to purchase all assets (intellectual property, trademarks, customer contracts, regulatory filings and tangible/intangible assets) of Allecra Therapeutics GmbH (Germany).

The Court in France in the hearing held on July 30 had accepted the company's binding bid that was being submitted in concurrence of the Insolvency Administrator of Allecra Therapeutics SAS for the acquisition of assets including Intellectual Property Rights and Trademarks of Allecra Therapeutics SAS. The formal pronouncement of Order was to be made in short period of time.

"We are hopeful to get the order in o...